Literature DB >> 10565732

Uroselective alpha-blockade for benign prostatic hyperplasia: clinically significant or marketing savvy?

S A Kaplan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10565732     DOI： 10.1016/s0090-4295(99)00326-x

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  2 in total

1.  Multicenter, prospective, comparative cohort study evaluating the efficacy and safety of alfuzosin 10 mg with regard to blood pressure in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia with or without antihypertensive medications.

Authors:  Li Tao Zhang; Sung Won Lee; Kwangsung Park; Woo Sik Chung; Sae Woong Kim; Jae Seog Hyun; Doo Geon Moon; Sang-Kuk Yang; Ji Kan Ryu; Dae Yul Yang; Ki Hak Moon; Kweon Sik Min; Jong Kwan Park
Journal:  Clin Interv Aging       Date:  2015-01-17       Impact factor: 4.458

Review 2.  Does the prostatic vascular system contribute to the development of benign prostatic hyperplasia?

Authors:  Mohamed A Ghafar; Peter J Puchner; Aristotelis G Anastasiadis; Mark A Cabelin; Ralph Buttyan
Journal:  Curr Urol Rep       Date:  2002-08       Impact factor: 2.862
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.